[Clinical case of congenital cleft palate in 22q11.2 deletion syndrome]

O V Ginter1, L S Namazova-Baranova2, T Ya Mospan1

  • 1National Medical Research Center of Children's Health, Moscow.

Stomatologiia
|March 5, 2019
PubMed

Insights

This case study highlights 22q11.2 deletion syndrome, a genetic disorder causing congenital cleft palate and impacting facial development. Early, multidisciplinary care is crucial for optimal surgical outcomes and preventing maxillofacial growth issues.

Area of Science:

  • Genetics
  • Pediatric Surgery
  • Endocrinology

Background:

  • 22q11.2 deletion syndrome is a genetic disorder associated with various congenital anomalies.
  • Congenital cleft palate is a common manifestation, significantly impacting feeding, speech, and facial aesthetics.
  • Systemic disorders, particularly endocrine abnormalities, are frequently observed in 22q11.2 deletion syndrome and influence craniofacial development.

Observation:

  • A clinical case of congenital cleft palate in a patient with 22q11.2 deletion syndrome is presented.
  • The patient exhibited concurrent systemic disorders that complicated the perioperative period and functional indicators.
  • Endocrine disorders characteristic of 22q11.2 deletion syndrome were noted to affect facial development.

Findings:

  • The interplay between cleft palate, 22q11.2 deletion syndrome, and associated systemic/endocrine disorders presents unique surgical challenges.
  • Functional indicators and perioperative management require careful consideration due to the syndrome's systemic impact.
  • Facial development is directly influenced by the endocrine dysfunctions present in 22q11.2 deletion syndrome.

Implications:

  • A multidisciplinary approach is essential for managing patients with 22q11.2 deletion syndrome and cleft palate.
  • Early and coordinated interventions can optimize treatment outcomes for cleft repair.
  • Proactive management of systemic and endocrine issues can prevent postoperative disturbances in maxillofacial development.

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
414
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
768
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
609
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
933
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.4K
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
996